Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study.

• Tác giả: Sarit Assouline, Marc-Étienne Beaudet, Lambert Busque, Inès Chamakhi, Ghislain Cournoyer, Robert Delage, Pierre Desjardins, Vincent Ethier, Michaël Harnois, Marc Lalancette, Pierre Laneuville, Luigina Mollica, Hanane Moussa, Harold Olney, Natasha Szuber, Danielle Talbot
• Ngôn ngữ: eng
• Thông tin xuất bản: United States : Blood cancer journal , 2025
• Bộ sưu tập: NCBI
• ID: 696055

Tóm tắt

[Image: see text]